Oral Anticoagulant Discontinuation, Adherence Patterns, Hospitalizations and Costs in Non-Valvular Atrial Fibrillation (NVAF) Patients

NCT02792335 · clinicaltrials.gov ↗

COMPLETED

Status

28000

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: apixaban
DRUG: dabigatran
DRUG: rivaroxaban
DRUG: warfarin

Sponsor

Bristol-Myers Squibb